Evidence map›Paper›PMID 40266808›Full record

ArticleInsects2025

Screening the Resistance of Male

Hamidou Maiga, Abel Souro Millogo, Koama Bayili, Etienne Bilgo, Inoussa Toe, Roch Kounbobr Dabiré, Jeremy Bouyer, Abdoulaye Diabaté

Abstract read
In one paragraph

Article in Insects, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Age-dependent mating dynamics, body size, and sex ratio in colonisedCurrent research in parasitology & vector-borne diseases · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hamidou MaigaInstitut de Recherche en Sciences de la Santé, Bobo-Dioulasso 01 BP 545, Burkina Faso.ORCID 0000-0001-8662-4700
Abel Souro MillogoInstitut de Recherche en Sciences de la Santé, Bobo-Dioulasso 01 BP 545, Burkina Faso.
Koama BayiliInstitut de Recherche en Sciences de la Santé, Bobo-Dioulasso 01 BP 545, Burkina Faso.ORCID 0000-0003-2670-4543
Etienne BilgoInstitut de Recherche en Sciences de la Santé, Bobo-Dioulasso 01 BP 545, Burkina Faso.
Inoussa ToeInstitut de Recherche en Sciences de la Santé, Bobo-Dioulasso 01 BP 545, Burkina Faso.ORCID 0009-0001-8552-6954
Roch Kounbobr DabiréInstitut de Recherche en Sciences de la Santé, Bobo-Dioulasso 01 BP 545, Burkina Faso.ORCID 0000-0002-3471-3506
Jeremy BouyerASTRE, Cirad-Département BIOS, INRAE, Université de Montpellier, Plateforme Technologique CYROI, Sainte-31 Clotilde, 97490 La Réunion, France.ORCID 0000-0002-1913-416X
Abdoulaye DiabatéInstitut de Recherche en Sciences de la Santé, Bobo-Dioulasso 01 BP 545, Burkina Faso.

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundGenetic control tools, such as the sterile insect technique (SIT) and genetically modified mosquitoes (GMMs), require releasing males comparable to their wild counterparts. Ensuring that released males do not exhibit higher insecticide resistance is critical. This study assessed the phenotypic characteristics and insecticide susceptibility of key dengue and malaria vector species.

methodsPhenotypic resistance to deltamethrin (0.05%) was tested in two-to-five-day-old male and female

resultsMortality rates were similar between male and female

conclusionThis study highlights sex-specific differences in body size and insecticide susceptibility. Integrating these analyses into vector management programs is essential for the success and sustainability of SIT- and GMM-based interventions targeting malaria and dengue vectors. Implications for integrating genetic control strategies are discussed.

Indexed as

deltamethrinmalesmosquito controlsterile insect technique

Identifiers

PMID40266808
PMCPMC11943260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.